The potential for Artificial Intelligence (AI) to revolutionise dementia diagnosis, treatment, and care will be in the spotlight at the Alzheimer’s Disease International (ADI) 36th international conference in Kraków, Poland, starting tomorrow – 24 – 26 April – Tickets can be booked for in-person and online here.
As the global community grapples with the challenges posed by dementia, AI offers promising avenues for early detection, innovative caregiving solutions, and improved support for both patients and caregivers.
The conference brings together leading experts and researchers from around the world to delve into the transformative impact of AI in dementia care.
Paola Barbarino, CEO of ADI, highlights the potential of AI to address the staggering economic burden of dementia, which currently stands at 1.3 trillion dollars annually and is projected to rise to 2.8 trillion dollars by 2030.
Ms Sandra Challma, CEO of Cognes, will discuss AI’s role in enabling early dementia detection through behavioural monitoring, utilising data from diverse sources including brain imaging and everyday behaviours captured through smart devices.
Professor Dame Louise Robbinson, ADI’s Co-Chief Scientific Advisor, will present AI’s potential in identifying blood biomarkers associated with Alzheimer’s disease, paving the way for early interventions and precise diagnoses.
James Brown, the co-founder of Supersense Technologies, will focus on AI applications in dementia caregiving, and the role of monitoring systems in detecting subtle changes in behaviour and emotional states.
With 55 million people currently living with dementia worldwide, a number projected to triple by 2050, the conference is bound to add to the dialogue surrounding AI’s potential in transforming dementia care.
